Molecular Therapeutic Advances for Neurodegenerative Diseases
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: 25 May 2025 | Viewed by 49
Special Issue Editor
Interests: neurodegenerative diseases; neurodegeneration; neurological disorders; Parkinson’s disease; probiotics; neuropathic pain; stem cells
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Special Issue, titled “Molecular Therapeutic Advances for Neurodegenerative Diseases”, focuses on the latest research and developments in understanding and treating neurodegenerative diseases at the molecular level. It aims to highlight innovative therapeutic strategies, including the identification of new molecular targets and the development of novel treatments to combat diseases, such as Alzheimer’s, Parkinson’s, stroke and other neurological disorders.
We are looking for a variety of manuscript types, including the following:
Original Research Articles: Detailed studies presenting new data on molecular mechanisms and therapeutic approaches for neurodegenerative diseases.
Review Articles: Comprehensive overviews of current knowledge and recent advancements in the field.
Communications: Brief reports on novel findings or preliminary data that can stimulate further research.
Dr. Vanessa Castelli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegenerative diseases
- neurodegeneration
- neurological disorders
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
